The Trump administration has promoted its Most Favored Nation agreements with pharmaceutical companies as a breakthrough on drug pricing, but recent SEC filings reveal that at least some of the 16…
News Feb 27, 2026The proposed GLOBE and GUARD models are mandatory CMMI programs with savings potential for the Medicare program.
Press Releases Feb 25, 2026In response to this evening’s State of the Union Address and President Trump’s statements on prescription drug prices, which focused primarily on TrumpRx and codifying a Most Favored Nation…
News Feb 13, 2026A recent report from DLA Piper argues that Medicare drug price negotiation is failing to deliver meaningful savings to seniors, but the analysis relies on false assumptions and flawed methodology…
News Feb 6, 2026The Trump administration rolled out TrumpRx.gov, a new federal website intended to connect patients with manufacturer discounts on roughly 40 prescription drugs.
Press Releases Feb 5, 2026Yesterday, the Federal Trade Commission (FTC) announced a settlement with Cigna’s Express Scripts, resolving claims that the pharmacy benefit manager engaged in practices that artificially inflated…
Press Releases Feb 5, 2026This evening, the Trump administration rolled out TrumpRx.gov, a new federal website intended to connect patients with manufacturer discounts on certain high-cost prescription drugs.
Press Releases Feb 3, 2026Today, President Trump signed into law a government spending bill that includes bipartisan prescription drug pricing reforms long supported by Patients For Affordable Drugs Now.
News Jan 30, 2026The third round of expensive prescription drugs selected for Medicare negotiation were announced this week, covering medications that account for $27 billion in Medicare spending.
News Jan 23, 2026The House passed a government spending bill on Thursday that includes key drug price reforms that P4AD has consistently pushed for since 2023.
1:49 · Watch on YouTube
3:50 · Watch on YouTube
0:51 · Watch on YouTube
